Profound Medical Corp Stock Current Valuation
| PROF Stock | USD 6.41 0.16 2.56% |
Valuation analysis of Profound Medical Corp helps investors to measure Profound Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The Profound Medical's current Enterprise Value is estimated to increase to about 206.9 M, while Enterprise Value Over EBITDA is projected to decrease to (7.17). Fundamental drivers impacting Profound Medical's valuation include:
Undervalued
Today
Please note that Profound Medical's price fluctuation is somewhat reliable at this time. Calculation of the real value of Profound Medical Corp is based on 3 months time horizon. Increasing Profound Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Profound stock is determined by what a typical buyer is willing to pay for full or partial control of Profound Medical Corp. Since Profound Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Profound Stock. However, Profound Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.41 | Real 8.36 | Target 15.3 | Hype 6.3 | Naive 5.8 |
The real value of Profound Stock, also known as its intrinsic value, is the underlying worth of Profound Medical Corp Company, which is reflected in its stock price. It is based on Profound Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Profound Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Profound Medical Corp helps investors to forecast how Profound stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Profound Medical more accurately as focusing exclusively on Profound Medical's fundamentals will not take into account other important factors: Profound Medical Corp Company Current Valuation Analysis
Profound Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Profound Medical Current Valuation | 176.75 M |
Most of Profound Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Profound Medical Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Profound Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Profound Medical is extremely important. It helps to project a fair market value of Profound Stock properly, considering its historical fundamentals such as Current Valuation. Since Profound Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Profound Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Profound Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Profound Current Valuation Historical Pattern
Today, most investors in Profound Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Profound Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Profound Medical current valuation as a starting point in their analysis.
Profound Medical Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Profound Medical Corp has a Current Valuation of 176.75 M. This is 98.77% lower than that of the Health Care Equipment & Supplies sector and 98.58% lower than that of the Health Care industry. The current valuation for all United States stocks is 98.94% higher than that of the company.
Profound Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Profound Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Profound Medical could also be used in its relative valuation, which is a method of valuing Profound Medical by comparing valuation metrics of similar companies.Profound Medical is currently under evaluation in current valuation category among its peers.
Profound Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Profound Medical from analyzing Profound Medical's financial statements. These drivers represent accounts that assess Profound Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Profound Medical's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 355.5M | 230.7M | 221.9M | 177.3M | 203.9M | 252.8M | |
| Enterprise Value | 273.2M | 164.9M | 183.6M | 159.0M | 182.8M | 206.9M |
Profound Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Profound Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Profound Medical's managers, analysts, and investors.Environmental | Governance | Social |
Profound Fundamentals
| Return On Equity | -0.9 | ||||
| Return On Asset | -0.45 | ||||
| Operating Margin | (3.17) % | ||||
| Current Valuation | 176.75 M | ||||
| Shares Outstanding | 30.03 M | ||||
| Shares Owned By Insiders | 7.22 % | ||||
| Shares Owned By Institutions | 37.11 % | ||||
| Number Of Shares Shorted | 382.24 K | ||||
| Price To Book | 6.38 X | ||||
| Price To Sales | 20.89 X | ||||
| Revenue | 7.2 M | ||||
| Gross Profit | 5.57 M | ||||
| EBITDA | (26.78 M) | ||||
| Net Income | (28.57 M) | ||||
| Cash And Equivalents | 46.21 M | ||||
| Cash Per Share | 2.21 X | ||||
| Total Debt | 7.94 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 17.36 X | ||||
| Book Value Per Share | 1.26 X | ||||
| Cash Flow From Operations | (22.3 M) | ||||
| Short Ratio | 5.12 X | ||||
| Earnings Per Share | (1.34) X | ||||
| Target Price | 15.3 | ||||
| Number Of Employees | 131 | ||||
| Beta | 0.83 | ||||
| Market Capitalization | 187.68 M | ||||
| Total Asset | 43.91 M | ||||
| Retained Earnings | (217.93 M) | ||||
| Working Capital | 35.53 M | ||||
| Current Asset | 9 K | ||||
| Current Liabilities | 761 K | ||||
| Net Asset | 43.91 M |
About Profound Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Profound Medical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Profound Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Profound Medical Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:Check out Profound Medical Piotroski F Score and Profound Medical Altman Z Score analysis. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.34) | Revenue Per Share | Quarterly Revenue Growth 0.639 | Return On Assets | Return On Equity |
The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.